CooperVision has announced plans to reorganise its soft contact lens portfolio in the UK and Ireland by transitioning, in large part, to silicone hydrogel production.
The move, the company stated, was designed to focus its efforts on offering its most innovative optical designs and advanced material technologies to eyecare professionals and wearers – and “pave the way for future innovation”.
The transition will occur over the next two years, and will involve phasing out some of the company’s Biomedics and Proclear hydrogel products from 31 October 2027.
Lara Drury, director of portfolio brand marketing EMEA, CooperVision, said: “We’re committed to continuously refresh our portfolio and bring innovative optical designs and advanced material technologies to market. While we’re making changes to our current offering, we’ll continue to offer the widest range of silicone hydrogel contact lenses – with over 250,000 correction options – ensuring strong support for both eyecare practitioners and wearers.”
The company is currently expanding its global manufacturing capabilities to meet demand for its silicone hydrogel portfolio, with investment in advanced infrastructure, production systems and technical expertise.
CooperVision said it was working with customers “to ensure a smooth transition”.